NEW YORK (GenomeWeb News) – A consortium of European research partners will use €9.5 million ($12.3 million) from the EU to trawl the trenches of the deep seas in search of organisms that could be used to develop bioactive compounds for treating diseases and for nutritional and cosmetic applications.

Led by researchers at the University of Aberdeen and the University of Leuven, the 24 PharmSea initiative partners from 14 countries will collect and screen mud and sediment samples from deep oceanic trenches to discover those compounds, KU Leuven said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.